The Tissue Procurement Shared Resource (TPSR) at the Ohio State University (OSU) was established on the initial award by the NCI for the OSU Comprehensive Cancer Center (CCC). In 1987, the TPSR was awarded an NCI grant for the Cooperative Human Tissue Network (CHTN) and in 1995, was again awarded an NCI grant for the AIDS Malignancy Bank (AMB). Together, these three grants comprise the TPSR in the Department of Pathology and indirectly support each other through consolidation of effort. The TPSR prospectively procures remnant human specimens for CCC research investigators. All applications require Institutional Review Board (IRB) approval and then specimens are provided, determined by the members' need and subject to availability. Procurement of tissue specimens from OSU and Grant Hospitals are prioritized for CCC investigators. Research specimens distributed to investigators are accompanied by donor information including age, gender and race and pathologist's gross and microscopic diagnosis. TPSR personnel gather additional medical information such as smoking history, radiation, chemotherapy, and other pertinent facts regarding the patient through medical records. All specimens are uniquely coded to assure patient confidentiality. TPSR consistently procures and distributes approximately 3,000 specimens per year from OSU and Grant Hospitals to more than 35 CCC members. The TPSR has been invaluable to CCC investigators' research, measured by a consistent number of original articles published ear year in peer-reviewed journals. Moreover, in this request for renewal, the TPSR is adding laser capture microdissection (LCM) technology for CC investigators use to enhance the value of tissue specimens used in research applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-27
Application #
6563727
Study Section
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
27
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Kelly, Rachel S; Lasky-Su, Jessica; Yeung, Sai-Ching J et al. (2018) Integrative omics to detect bacteremia in patients with febrile neutropenia. PLoS One 13:e0197049
Straus, David J; Jung, Sin-Ho; Pitcher, Brandelyn et al. (2018) CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. Blood 132:1013-1021
Kim, Yangjin; Yoo, Ji Young; Lee, Tae Jin et al. (2018) Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy. Proc Natl Acad Sci U S A 115:4927-4932
Wang, Xinmei; Kwak, Kwang Joo; Yang, Zhaogang et al. (2018) Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma. PLoS One 13:e0198552
Callahan, Catherine L; Bonner, Matthew R; Nie, Jing et al. (2018) Lifetime exposure to ambient air pollution and methylation of tumor suppressor genes in breast tumors. Environ Res 161:418-424
Gopalakrishnan, Bhavani; Cheney, Carolyn; Mani, Rajeswaran et al. (2018) Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia. Oncotarget 9:9706-9713
Hankey, William; Frankel, Wendy L; Groden, Joanna (2018) Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev 37:159-172
Felix, A S; Brasky, T M; Cohn, D E et al. (2018) Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. Int J Cancer 142:1102-1115
Stover, Daniel G; Parsons, Heather A; Ha, Gavin et al. (2018) Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. J Clin Oncol 36:543-553
Jacobsen, Paul B; DeRosa, Antonio P; Henderson, Tara O et al. (2018) Systematic Review of the Impact of Cancer Survivorship Care Plans on Health Outcomes and Health Care Delivery. J Clin Oncol 36:2088-2100

Showing the most recent 10 out of 2602 publications